Genetic Analysis AS
Research Genetic Analysis AS (GEAN) on Bullrun: market cap NOK 49.05M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGEAN
- ExchangeST
- CountryNorway
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyNOK
- Market capNOK 49.05M
- Financial periodQ1 2026
- RevenueNOK 3.85M
- Net income-NOK 4.61M
- Free cash flow-NOK 6.40M
- Gross margin73.2%
Valuation Snapshot
latest market cap is NOK 49.05M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | NOK 16.71M | -NOK 11.41M | -NOK 3.13M | 71.9% | -0.19 | NOK 24.03M | NOK 6.40M | NOK 27.08M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | NOK 49.05M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 NOK.
About Genetic Analysis AS
Genetic Analysis AS, a science-based diagnostic company, engages in the research, development, manufacturing, and sale of diagnostic test solutions for human microbiome in the United States, Europe, and internationally. The company offers GA-map MHI Gut Health Test, a microbiome-based diagnostic test for antibiotic-induced microbiome imbalances; GA-map Dysbiosis Test, a diagnostic microbiome test that detects and characterizes dysbiosis; GA-map Discovery, a microbiome research assay;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Genetic Analysis AS's market cap?
Genetic Analysis AS's market capitalization is NOK 49.05M.
What does Genetic Analysis AS do?
Genetic Analysis AS, a science-based diagnostic company, engages in the research, development, manufacturing, and sale of diagnostic test solutions for human microbiome in the United States, Europe, and internationally.